Collegium Pharmaceutical Inc (COLL)
36.42
+0.58
(+1.63%)
USD |
NASDAQ |
Apr 26, 16:00
36.42
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Cash from Investing (TTM): -70.81M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -70.81M |
September 30, 2023 | -46.66M |
June 30, 2023 | -42.95M |
March 31, 2023 | -1.69M |
December 31, 2022 | -573.69M |
September 30, 2022 | -573.27M |
June 30, 2022 | -573.43M |
March 31, 2022 | -573.69M |
December 31, 2021 | -1.944M |
September 30, 2021 | -2.91M |
June 30, 2021 | -5.037M |
March 31, 2021 | -6.553M |
December 31, 2020 | -373.77M |
September 30, 2020 | -373.18M |
Date | Value |
---|---|
June 30, 2020 | -372.13M |
March 31, 2020 | -370.76M |
December 31, 2019 | -6.438M |
September 30, 2019 | -7.322M |
June 30, 2019 | -8.688M |
March 31, 2019 | -8.56M |
December 31, 2018 | -24.35M |
September 30, 2018 | -22.75M |
June 30, 2018 | -20.38M |
March 31, 2018 | -20.08M |
December 31, 2017 | -0.99M |
September 30, 2017 | -1.159M |
June 30, 2017 | -0.93M |
March 31, 2017 | -3.006M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-573.69M
Minimum
Mar 2022
-1.69M
Maximum
Mar 2023
-209.73M
Average
-46.66M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Immunogen Inc (DELISTED) | -1.889M |
Supernus Pharmaceuticals Inc | 268.73M |
AnaptysBio Inc | 144.75M |
Recursion Pharmaceuticals Inc | -10.23M |
Nuvalent Inc | -143.53M |